pentobarbital will lessen the level or result of nitrendipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will decrease the extent or impact of tamoxifen by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will decrease the extent or effect of vardenafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Check Closely (1)pentobarbital will reduce the level or impact of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or effect of isradipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will decrease the level or influence of buprenorphine buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the level or result of eltrombopag by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Observe.
pentobarbital will reduce get more info the level or outcome of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital decreases amounts of toremifene by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. CYP3A4 inducers boost amount of toremifene metabolism, reducing the regular-condition concentration in serum.
pentobarbital will lower the extent or effect of lapatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lessen the level or result of quetiapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the extent or effect of vinblastine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
pentobarbital will lessen the extent or impact of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Sturdy CYP3A4 inducers may perhaps lessen suvorexant efficacy; if improved suvorexant dose expected, don't exceed 20 mg/working day
pentobarbital will decrease the level or impact of doxorubicin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.